Lavrov calls to coordinate Russian, US military action in SyriaRussian Politics & Diplomacy September 22, 21:05
Lavrov blames Obama administration for souring Russia-US tiesRussian Politics & Diplomacy September 22, 20:41
Waging war on Korean Peninsula inadmissible, says LavrovRussian Politics & Diplomacy September 22, 20:36
Russian Northern Fleet completes drills in ArcticMilitary & Defense September 22, 18:01
OPEC and non-OPEC countries to continue talks on oil production cut dealBusiness & Economy September 22, 17:28
Russian pair figure skaters Kavaguti, Smirnov retire from sportSport September 22, 16:48
Record number of delegations register for St. Petersburg-hosted IPU AssemblyRussian Politics & Diplomacy September 22, 16:47
Astronauts to make quickest trip ever to ISS in DecemberScience & Space September 22, 16:27
Russian frigate Admiral Essen returns to Crimea after mission in MediterraneanMilitary & Defense September 22, 16:24
MOSCOW, October 10 (Itar-Tass) — Russia’s ex-finance minister Alexei Kudrin insists that the country should invest more money into healthcare and less into defence.
“Russia still has to go down the path of increasing expenditures on healthcare. In this respect I would inject less into military needs than into healthcare,” he told the forum dealing with the Sixth Millennium Development Goal MDG-6 that opened in Moscow on Monday.
He reiterated his position saying that “an increase in military spending poses a threat to the support and development of healthcare and education programs.” “This is the reason of my conflict with the Russian incumbent president.”
In late September Alexei Kudrin resigned after a disagreement with President Dmitry Medvedev’s economic policy targeted at increasing expenditures on defence.
Speaking about reaching the development goals, mainly the goal to combat HIV/AIDS, malaria and other diseases, Kudrin stressed the need for creating a mechanism that would attract large pharmaceutical corporations to work in less developed countries and for the poor, as well-to-do people have access to most state-of-the-art medicines.